(Q38086743)

28 August 2017

title

Protein fibrillation and nanoparticle interactions: opportunities and challenges (English)

1 reference

28 August 2017

0 references

1 reference

1

1 reference

28 August 2017

4

1 reference

28 August 2017

Hamid R Kalhor

2

1 reference

28 August 2017

Sophie Laurent

series ordinal

3

1 reference

28 August 2017

language of work or name

English

0 references

publication date

1 April 2013

1 reference

28 August 2017

1 reference

28 August 2017

volume

5

1 reference

28 August 2017

issue

7

1 reference

28 August 2017

page(s)

2570-2588

1 reference

Protein folding and misfolding

28 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Alzheimer's amyloid fibrils: structure and assembly

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Mapping abeta amyloid fibril secondary structure using scanning proline mutagenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

A general model for amyloid fibril assembly based on morphological studies using atomic force microscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Amyloid-like features of polyglutamine aggregates and their assembly kinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Effect of nanoparticles on protein folding and fibrillogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Amyloid β-protein aggregation produces highly reproducible kinetic data and occurs by a two-phase process

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Structural models of amyloid-like fibrils

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Inhibitors of amyloid toxicity based on beta-sheet packing of Abeta40 and Abeta42.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Experimental constraints on quaternary structure in Alzheimer's beta-amyloid fibrils

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Charge substitution shows that repulsive electrostatic interactions impede the oligomerization of Alzheimer amyloid peptides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Amyloid-beta aggregation

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

A beta oligomers - a decade of discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Soluble oligomers of amyloid Beta protein facilitate hippocampal long-term depression by disrupting neuronal glutamate uptake

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Intracerebroventricular Administration of Amyloid β-protein Oligomers Selectively Increases Dorsal Hippocampal Dialysate Glutamate Levels in the Awake Rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Influence of the physiochemical properties of superparamagnetic iron oxide nanoparticles on amyloid β protein fibrillation in solution

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

The neurobiology of zinc in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Conformational constraints for amyloid fibrillation: the importance of being unfolded

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Disrupting established tumor blood vessels: an emerging therapeutic strategy for cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

The SR-mitochondria interaction: a new player in cardiac pathophysiology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Regulation and critical role of potassium homeostasis in apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Calcium dyshomeostasis and intracellular signalling in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Beta-2 microglobulin is an amyloidogenic protein in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

The intrachain disulfide bond of beta(2)-microglobulin is not essential for the immunoglobulin fold at neutral pH, but is essential for amyloid fibril formation at acidic pH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

The repeat domain of the melanosome fibril protein Pmel17 forms the amyloid core promoting melanin synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

A mathematical model of the kinetics of beta-amyloid fibril growth from the denatured state

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

A kinetic model for amyloid formation in the prion diseases: importance of seeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

On the nucleation and growth of amyloid beta-protein fibrils: detection of nuclei and quantitation of rate constants

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Kinetics of aggregation of synthetic beta-amyloid peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Light scattering analysis of fibril growth from the amino-terminal fragment beta(1-28) of beta-amyloid peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Aggregation and fibrillation of bovine serum albumin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Effect of environmental factors on the kinetics of insulin fibril formation: elucidation of the molecular mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Requirements for generating sigmoidal time-course aggregation in nucleation-dependent polymerization model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

The aggregation kinetics of Alzheimer's beta-amyloid peptide is controlled by stochastic nucleation

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

The effect of macromolecular crowding on protein aggregation and amyloid fibril formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

A facile method for expression and purification of the Alzheimer's disease-associated amyloid beta-peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Secondary nucleation and accessible surface in insulin amyloid fibril formation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Branching in amyloid fibril growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

An analytical solution to the kinetics of breakable filament assembly

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Molecular chaperones: pathways and networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Macromolecular crowding: an important but neglected aspect of the intracellular environment

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Effects of macromolecular crowding on protein folding and aggregation

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Natively unfolded proteins: a point where biology waits for physics

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Implications of macromolecular crowding for protein assembly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Macromolecular crowding accelerates amyloid formation by human apolipoprotein C-II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Dual effect of amino modified polystyrene nanoparticles on amyloid β protein fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

The molecular chaperone, alpha-crystallin, inhibits amyloid formation by apolipoprotein C-II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

The effects of molecular crowding on the amyloid fibril formation of alpha-lactalbumin and the chaperone action of alpha-casein

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Stepwise dynamics of epitaxially growing single amyloid fibrils

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Direct observation of Abeta amyloid fibril growth and inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Direct observation of amyloid fibril growth monitored by thioflavin T fluorescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

In situ atomic force microscopy study of Alzheimer's beta-amyloid peptide on different substrates: new insights into mechanism of beta-sheet formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

AFM and STM study of beta-amyloid aggregation on graphite.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Rapid self-assembly of alpha-synuclein observed by in situ atomic force microscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Amyloid-a state in many guises: survival of the fittest fibril fold

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Monoclonal immunoglobulin deposition disease: light chain and light and heavy chain deposition diseases and their relation to light chain amyloidosis. Clinical features, immunopathology, and molecular analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Micro-imaging of amyloid in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Detection and characterization of aggregates, prefibrillar amyloidogenic oligomers, and protofibrils using fluorescence spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Amyloidogenic self-assembly of insulin aggregates probed by high resolution atomic force microscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Amyloid nucleation and hierarchical assembly of Ure2p fibrils. Role of asparagine/glutamine repeat and nonrepeat regions of the prion domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

The binding of thioflavin-T to amyloid fibrils: localisation and implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Fluorometric determination of amyloid fibrils in vitro using the fluorescent dye, thioflavin T1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Small organic probes as amyloid specific ligands--past and recent molecular scaffolds

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Amyloid oligomers: spectroscopic characterization of amyloidogenic protein states.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Amyloid beta-protein oligomerization: prenucleation interactions revealed by photo-induced cross-linking of unmodified proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Structural study of metastable amyloidogenic protein oligomers by photo-induced cross-linking of unmodified proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Inhibition of amyloid formation by ionic liquids: ionic liquids affecting intermediate oligomers

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Analysis of amyloid aggregates using agarose gel electrophoresis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Molecular structure of amyloid fibrils: insights from solid-state NMR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Fibrils with parallel in-register structure constitute a major class of amyloid fibrils: molecular insights from electron paramagnetic resonance spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Solid-state NMR as a method to reveal structure and membrane-interaction of amyloidogenic proteins and peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Mechanism of thioflavin T binding to amyloid fibrils.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Optical properties of amyloid stained by Congo red: history and mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Methods for staining amyloid in tissues: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Is Congo red an amyloid-specific dye?

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Imaging linear birefringence and dichroism in cerebral amyloid pathologies

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Amyloid: toward terminology clarification. Report from the Nomenclature Committee of the International Society of Amyloidosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Amyloid associated with elastin-staining laminar aggregates in the lungs of patients diagnosed with acute respiratory distress syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Computational approaches to fibril structure and formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

CHARMM: the biomolecular simulation program

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

GROMACS: fast, flexible, and free

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Simulations as analytical tools to understand protein aggregation and predict amyloid conformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Principles governing oligomer formation in amyloidogenic peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

A molecular dynamics approach to the structural characterization of amyloid aggregation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Effect of beta-sheet propensity on peptide aggregation

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Conformational transition of amyloid beta-peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

A strand-loop-strand structure is a possible intermediate in fibril elongation: long time simulations of amyloid-beta peptide (10-35).

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Emerging ideas on the molecular basis of protein and peptide aggregation

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

What determines the structure and stability of KFFE monomers, dimers, and protofibrils?

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Charge attraction and beta propensity are necessary for amyloid fibril formation from tetrapeptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

A possible role for pi-stacking in the self-assembly of amyloid fibrils

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Prediction of "aggregation-prone" and "aggregation-susceptible" regions in proteins associated with neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Characterizing amyloid‐beta protein misfolding from molecular dynamics simulations with explicit water

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Directed assembly of block copolymer blends into nonregular device-oriented structures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Superparamagnetic iron oxide nanoparticles (SPIONs): development, surface modification and applications in chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Therapeutic benefits from nanoparticles: the potential significance of nanoscience in diseases with compromise to the blood brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Superparamagnetic iron oxide nanoparticles: promises for diagnosis and treatment of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Small molecule inhibitors of aggregation indicate that amyloid beta oligomerization and fibrillization pathways are independent and distinct

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Inhibition of toxicity in the beta-amyloid peptide fragment beta -(25-35) using N-methylated derivatives: a general strategy to prevent amyloid formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Inhibition of the formation of amyloid β-protein fibrils using biocompatible nanogels as artificial chaperones

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Fullerene inhibits beta-amyloid peptide aggregation

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Modulation of gamma-secretase specificity using small molecule allosteric inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Recent advances in the identification of gamma-secretase inhibitors to clinically test the Abeta oligomer hypothesis of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Structure-activity relationships in peptide modulators of β-amyloid protein aggregation: variation in α,α-disubstitution results in altered aggregate size and morphology

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Epitope and isotype specificities of antibodies to beta -amyloid peptide for protection against Alzheimer's disease-like neuropathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Loss of autophagy in the central nervous system causes neurodegeneration in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Opposing activities protect against age-onset proteotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Synthesis of scyllo-inositol derivatives and their effects on amyloid beta peptide aggregation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

The molecular mechanisms of the anti-amyloid effects of phenols

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Approaches to discovery and characterization of inhibitors of amyloid beta-peptide polymerization

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Influence of dendrimer's structure on its activity against amyloid fibril formation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Kinetics of insulin aggregation in aqueous solutions upon agitation in the presence of hydrophobic surfaces

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Analysis of plasma protein adsorption on polymeric nanoparticles with different surface characteristics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Interactions of blood proteins with poly(isobutylcyanoacrylate) nanoparticles decorated with a polysaccharidic brush

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Understanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Engineered nanoparticles for biomolecular imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

A new approach for the in vitro identification of the cytotoxicity of superparamagnetic iron oxide nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Protein adsorption onto silica nanoparticles: conformational changes depend on the particles' curvature and the protein stability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Protein-nanoparticle interactions: opportunities and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Nanoparticles as catalysts for protein fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Nanodiagnostics: a new frontier for clinical laboratory medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Nanotools for megaproblems: probing protein misfolding diseases using nanomedicine modus operandi

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Nanoparticle-based detection in cerebral spinal fluid of a soluble pathogenic biomarker for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

An alternative approach to amyloid fibrils morphology: CdSe/ZnS quantum dots labelled beta-amyloid peptide fragments Abeta (31-35), Abeta (1-40) and Abeta (1-42).

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Inhibition of Amyloid β Protein Fibrillation by Polymeric Nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Multifunctional Nanocarriers for diagnostics, drug delivery and targeted treatment across blood-brain barrier: perspectives on tracking and neuroimaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Brain-targeted delivery of Tempol-loaded nanoparticles for neurological disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Metal chelators coupled with nanoparticles as potential therapeutic agents for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Chapter 4 - Applications of nanotechnology in molecular imaging of the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Nanotechnological applications for the treatment of neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Therapeutic potential of controlled drug delivery systems in neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Nonviral siRNA delivery for gene silencing in neurodegenerative diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Targeted nanoparticles for drug delivery through the blood-brain barrier for Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Poly(n-butylcyanoacrylate) nanoparticles coated with polysorbate 80 for the targeted delivery of rivastigmine into the brain to treat Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Amyloid-beta associated with chitosan nano-carrier has favorable immunogenicity and permeates the BBB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Nucleation of protein fibrillation by nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Effect of surface concentration on secondary and tertiary conformational changes of lysozyme adsorbed on silica nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Emerging and potential therapies for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Biomolecular coronas provide the biological identity of nanosized materials

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

The Protein Corona Mediates the Impact of Nanomaterials and Slows Amyloid Beta Fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Physiological temperature has a crucial role in amyloid β in the absence and presence of hydrophobic and hydrophilic nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Cell "vision": complementary factor of protein corona in nanotoxicology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Toxicity evaluations of superparamagnetic iron oxide nanoparticles: cell "vision" versus physicochemical properties of nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Significance of cell "observer" and protein source in nanobiosciences

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Crucial ignored parameters on nanotoxicology: the importance of toxicity assay modifications and "cell vision"

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Direct conjugation of semiconductor nanocrystals to a globular protein to study protein-folding intermediates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Synthesis and characterization of fluorinated magnetic core-shell nanoparticles for inhibition of insulin amyloid fibril formation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

TiO2 nanoparticles promote beta-amyloid fibrillation in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Quantum dots as ultrasensitive nanoactuators and sensors of amyloid aggregation in live cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Inhibition of beta 1-40 amyloid fibrillation with N-acetyl-L-cysteine capped quantum dots

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Influence of fluorinated and hydrogenated nanoparticles on the structure and fibrillogenesis of amyloid beta-peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

PEGylated phospholipid nanomicelles interact with beta-amyloid((1-42)) and mitigate its beta-sheet formation, aggregation and neurotoxicity in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Inhibition of IAPP and IAPP(20-29) fibrillation by polymeric nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Prefibrillar amyloid aggregates could be generic toxins in higher organisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Stop-and-go kinetics in amyloid fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Interdisciplinary challenges and promising theranostic effects of nanoscience in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Graphene oxide strongly inhibits amyloid beta fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Synthesis, surface architecture and biological response of superparamagnetic iron oxide nanoparticles for application in drug delivery: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Cytotoxicity of Uncoated and Polyvinyl Alcohol Coated Superparamagnetic Iron Oxide Nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Plasma concentration gradient influences the protein corona decoration on nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Thioflavine T interaction with amyloid β-sheet structures

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

In-situ atomic force microscopy study of β-amyloid fibrillization

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Growth of nanowire superlattice structures for nanoscale photonics and electronics

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

Equilibrium cluster formation in concentrated protein solutions and colloids

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3NR33193H

21 January 2018

Identifiers

DOI

10.1039/C3NR33193H

1 reference

28 August 2017

1 reference